FDA Drug Recalls

Recalls / Class II

Class IID-1044-2020

Product

Daytrana (methylphenidate transdermal system) patches, Delivers 20 mg over 9 hours (2.2 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5554-3

Brand name
Daytrana
Generic name
Methylphenidate
Active ingredient
Methylphenidate
Route
Transdermal
NDCs
68968-5552, 68968-5553, 68968-5554, 68968-5555
FDA application
NDA021514
Affected lot / code info
Lo#t: 86081, Exp 04/2020; 86196, Exp 06/2020

Why it was recalled

Defective Delivery System: Out of specification for mechanical peel and shear.

Recalling firm

Firm
Noven Therapeutics, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
11960 Sw 144th St, Miami, Florida 33186-6109

Distribution

Quantity
11093 boxes
Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2020-03-02
FDA classified
2020-03-19
Posted by FDA
2020-03-25
Terminated
2023-05-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1044-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Daytrana · FDA Drug Recalls